Epidemiologist Ann Pulver found her research calling early. As an undergraduate at Boston University, she worked with schizophrenia patients and saw firsthand the devastation the disease can cause. She decided then to devote her career to fighting it.
Researchers have developed a chemical compound that could lead to a new treatment for Gaucher disease, the most common genetic disease among Ashkenazi Jews, which causes problems including anemia, poor blood clotting, an enlarged liver and spleen, bone damage and, in the most serious cases, neurological problems.The newly discovered compound
Scientists have pinpointed the gene mutation responsible for most cases of Usher syndrome type 1 in Ashkenazi Jews. The syndrome is a genetic disorder that causes deafness from birth and progressive blindness beginning before age 10.The discovery, first reported in The New England Journal of Medicine in April, will allow doctors to more easily and